Works by Al‐Kali, Aref

Results: 124

Leukemic Polyradiculopathy Due to Blastic Plasmacytoid Dendritic Cell Neoplasm.

Published in:

JAMA Neurology, 2015, v. 72, n. 8, p. 938, doi. 10.1001/jamaneurol.2015.0830

By:

Qubty, William F.;
Al-Kali, Aref;
Jones Jr., Lyell K.

Publication type:

Article

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00922-7

By:

Badar, Talha;
Vanegas, Yenny A. Moreno;
Nanaa, Ahmad;
Foran, James M.;
Al-Kali, Aref;
Mangaonkar, Abhishek;
Murthy, Hemant;
Alkhateeb, Hassan B.;
Viswanatha, David;
He, Rong;
Shah, Mithun;
Yi, Cecilia Arana;
Litzow, Mark R.;
Gangat, Naseema;
Tefferi, Ayalew;
Patnaik, Mrinal M.

Publication type:

Article

Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00891-x

By:

Abdelmagid, Maymona G.;
Al-Kali, Aref;
Litzow, Mark R.;
Begna, Kebede H.;
Hogan, William J.;
Patnaik, Mirinal S.;
Hashmi, Shahrukh K.;
Elliott, Michelle A.;
Alkhateeb, Hassan;
Karrar, Omer S.;
Fleti, Farah;
Elnayir, Mohammed H.;
Rivera, Candido E.;
Murthy, Hemant S.;
Foran, James M.;
Kharfan-Dabaja, Mohamed A.;
Badar, Talha;
Viswanatha, David S.;
Reichard, Kaaren K.;
Gangat, Naseema

Publication type:

Article

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x

By:

Shah, Mithun Vinod;
Tran, Elizabeth Ngoc Hoa;
Shah, Syed;
Chhetri, Rakchha;
Baranwal, Anmol;
Ladon, Dariusz;
Shultz, Carl;
Al-Kali, Aref;
Brown, Anna L.;
Chen, Dong;
Scott, Hamish S.;
Greipp, Patricia;
Thomas, Daniel;
Alkhateeb, Hassan B.;
Singhal, Deepak;
Gangat, Naseema;
Kumar, Sharad;
Patnaik, Mrinal M.;
Hahn, Christopher N.;
Kok, Chung Hoow

Publication type:

Article

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00818-6

By:

Al-Kali, Aref;
Nanaa, Ahmad;
Viswanatha, David;
He, Rong;
Nguyen, Phuong;
Jevremovic, Dragan;
Foran, James M.;
Yi, Cecelia Arana;
Greipp, Patricia T.;
Gangat, Naseema;
Patnaik, Mrinal;
Tefferi, Ayalew;
Litzow, Mark R.;
Mangaonkar, Abhishek A.;
Shah, Mithun Vinod;
Badar, Talha;
Alkhateeb, Hassan B.

Publication type:

Article

Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00812-y

By:

Abdallah, Mostafa;
McCullough, Kristen;
Ilyas, Rimal;
Begna, Kebede H.;
Al-Kali, Aref;
Litzow, Mark R.;
Hogan, William J.;
Mangaonkar, Abhishek;
Alkhateeb, Hassan;
Shah, Mithun V.;
Elliott, Michelle A.;
Foran, James M.;
Badar, Talha;
Palmer, Jeanne M.;
Yi, Cecilia Arana;
Sproat, Lisa;
Pardanani, Animesh;
Patnaik, Mrinal M.;
Olteanu, Horatiu;
Ketterling, Rhett P.

Publication type:

Article

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x

By:

Shah, Mithun Vinod;
Tran, Elizabeth Ngoc Hoa;
Shah, Syed;
Chhetri, Rakchha;
Baranwal, Anmol;
Ladon, Dariusz;
Shultz, Carl;
Al-Kali, Aref;
Brown, Anna L.;
Chen, Dong;
Scott, Hamish S.;
Greipp, Patricia;
Thomas, Daniel;
Alkhateeb, Hassan B.;
Singhal, Deepak;
Gangat, Naseema;
Kumar, Sharad;
Patnaik, Mrinal M.;
Hahn, Christopher N.;
Kok, Chung Hoow

Publication type:

Article

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.

Published in:

2023

By:

Al-Kali, Aref;
Nanaa, Ahmad;
Viswanatha, David;
He, Rong;
Nguyen, Phuong;
Jevremovic, Dragan;
Foran, James M.;
Yi, Cecelia Arana;
Greipp, Patricia T.;
Gangat, Naseema;
Patnaik, Mrinal;
Tefferi, Ayalew;
Litzow, Mark R.;
Mangaonkar, Abhishek A.;
Shah, Mithun Vinod;
Badar, Talha;
Alkhateeb, Hassan B.

Publication type:

Letter

Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Published in:

2023

By:

Abdallah, Mostafa;
McCullough, Kristen;
Ilyas, Rimal;
Begna, Kebede H.;
Al-Kali, Aref;
Litzow, Mark R.;
Hogan, William J.;
Mangaonkar, Abhishek;
Alkhateeb, Hassan;
Shah, Mithun V.;
Elliott, Michelle A.;
Foran, James M.;
Badar, Talha;
Palmer, Jeanne M.;
Yi, Cecilia Arana;
Sproat, Lisa;
Pardanani, Animesh;
Patnaik, Mrinal M.;
Olteanu, Horatiu;
Ketterling, Rhett P.

Publication type:

Letter

Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS- 911543 JAK2 inhibitor.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00780-9

By:

Gangat, Naseema;
Begna, Kebede H.;
Al-Kali, Aref;
Hogan, William;
Litzow, Mark;
Pardanani, Animesh;
Tefferi, Ayalew

Publication type:

Article

Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma.

Published in:

2022

By:

Alkhateeb, Hassan B.;
Mohty, Razan;
Greipp, Patricia;
Bansal, Radhika;
Hathcock, Matthew;
Rosenthal, Allison;
Murthy, Hemant;
Kharfan-Dabaja, Mohamed;
Bisneto Villasboas, Jose C.;
Bennani, Nora;
Ansell, Stephen M.;
Patnaik, Mrinal M.;
Litzow, Mark R.;
He, Rong;
Chen, Dong;
Al-Kali, Aref;
Kenderian, Saad S.;
Lin, Yi;
Shah, Mithun Vinod

Publication type:

Letter

Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00691-9

By:

Ghorab, Ahmad;
Al-Kali, Aref;
Elliot, Michelle;
Gangat, Naseema;
Alkhateeb, Hasan;
Shah, Mithun;
Liu, Yuanhang;
Yi, Cecilia Arana;
Murthy, Hemant;
Kharfan-Dabaja, Mohamed;
Tefferi, Ayalew;
Patnaik, Mrinal;
Litzow, Mark;
Badar, Talha

Publication type:

Article

Isolated anemia in patients with large granular lymphocytic leukemia (LGLL).

Published in:

Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00632-6

By:

Salama, Youssef;
Zhao, Fang;
Oliveira, Jennifer L.;
Yuan, Ji;
Jevremovic, Dragan;
Go, Ronald S.;
Ding, Wei;
Parikh, Sameer A.;
Shah, Mithun V.;
Hampel, Paul J.;
Al-Kali, Aref;
Morice, William G.;
Shi, Min

Publication type:

Article

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00622-8

By:

Mangaonkar, Abhishek A.;
Lasho, Terra L.;
Ketterling, Rhett P.;
Reichard, Kaaren K.;
Gangat, Naseema;
Al-Kali, Aref;
Begna, Kebede H.;
Pardanani, Animesh;
Al Ali, Najla H.;
Talati, Chetasi;
Sallman, David;
Padron, Eric;
Patnaik, Mrinal M.;
Tefferi, Ayalew;
Komrokji, Rami

Publication type:

Article

Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience.

Published in:

2021

By:

Nanaa, Ahmad;
Viswanatha, David;
Xie, Zhuoer;
Jevremovic, Dragan;
Nguyen, Phuong;
Salama, Mohamad E.;
Greipp, Patricia;
Bessonen, Kurt;
Gangat, Naseema;
Patnaik, Mrinal;
Pardanani, Animesh;
Alkhateeb, Hassan B.;
Shah, Mithun;
Hogan, William;
Tefferi, Ayalew;
Litzow, Mark;
He, Rong;
Al-Kali, Aref

Publication type:

Letter to the Editor

Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.

Published in:

2021

By:

Hampel, Paul J.;
Parikh, Sameer A.;
Call, Timothy G.;
Shah, Mithun V.;
Bennani, N. Nora;
Al-Kali, Aref;
Rabe, Kari G.;
Wang, Yucai;
Muchtar, Eli;
Leis, Jose F.;
Kenderian, Saad S.;
Koehler, Amber B.;
Schwager, Susan M.;
Slager, Susan L.;
Kay, Neil E.;
Hanson, Curtis A.;
Van Dyke, Daniel L.;
Shi, Min;
Ding, Wei

Publication type:

Letter

Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study.

Published in:

2021

By:

Xie, Zhuoer;
Nanaa, Ahmad;
Saliba, Antoine N.;
He, Rong;
Viswanatha, David;
Nguyen, Phuong;
Jevremovic, Dragan;
Greipp, Patricia;
Salama, Mohamad E.;
Gangat, Naseema;
Alkhateeb, Hassan B.;
Tefferi, Ayalew;
Litzow, Mark;
Patnaik, Mrinal;
Shah, Mithun;
Al-Kali, Aref

Publication type:

Letter

Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation.

Published in:

2021

By:

Joshi, Maansi;
Cook, Joselle;
McCullough, Kristen;
Nanaa, Ahmad;
Gangat, Naseema;
Foran, James M.;
Murthy, Hemant S.;
Kharfan-Dabaja, Mohamed A.;
Sproat, Lisa;
Palmer, Jeanne;
Pardanani, Animesh;
Tefferi, Ayalew;
Begna, Kebede;
Elliot, Michelle;
Al-Kali, Aref;
Patnaik, Mrinal;
Shah, Mithun V.;
Hogan, William J.;
Litzow, Mark R.;
Alkhateeb, Hassan B.

Publication type:

Letter to the Editor

Mayo Clinic experience with 1123 adults with acute myeloid leukemia.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00435-1

By:

Begna, Kebede H.;
Ali, Walid;
Naseema Gangat;
Elliott, Michelle A.;
Al-Kali, Aref;
Litzow, Mark R.;
Christopher Hook, C.;
Wolanskyj-Spinner, Alexandra P.;
Hogan, William J.;
Patnaik, Mrinal M.;
Pardanani, Animesh;
Zblewski, Darci L.;
Chen, Dong;
He, Rong;
Viswanatha, David;
Hanson, Curtis A.;
Ketterling, Rhett P.;
Tefferi, Ayalew

Publication type:

Article

Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia.

Published in:

2020

By:

Pophali, Prateek;
Matin, Aasiya;
Mangaonkar, Abhishek A.;
Carr, Ryan;
Binder, Moritz;
Al-Kali, Aref;
Begna, Kebede H.;
Reichard, Kaaren K.;
Alkhateeb, Hassan;
Shah, Mithun V.;
Tefferi, Ayalew;
Hogan, William J.;
Litzow, Mark R.;
Patnaik, Mrinal M.

Publication type:

Letter

A population-based study of chronic neutrophilic leukemia in the United States.

Published in:

2020

By:

Ruan, Gordon J.;
Smith, Caleb J.;
Day, Courtney;
Harmsen, William S.;
Zblewski, Darci L.;
Alkhateeb, Hassan;
Begna, Kebede;
Al-Kali, Aref;
Litzow, Mark R.;
Hogan, William;
Szuber, Natasha;
Gangat, Naseema;
Patnaik, Mrinal S.;
Pardanani, Animesh;
Elliott, Michelle A.;
Tefferi, Ayalew;
Go, Ronald S.;
Shah, Mithun V.

Publication type:

Letter

Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous lineage and acute lymphoblastic leukemia.

Published in:

2025

By:

Tessier, Steven;
McCullough, Kristen B.;
Gangat, Naseema;
Begna, Kebede H.;
Saliba, Antoine N.;
Mangoankar, Abhishek A.;
Shah, Mithun V.;
Hogan, William J.;
Patnaik, Mrinal M.;
Al-Kali, Aref;
Alkhateeb, Hassan B.

Publication type:

Letter to the Editor

Clinical outcomes of patients diagnosed with SETBP1 mutated myeloid neoplasms.

Published in:

Leukemia & Lymphoma, 2025, v. 66, n. 3, p. 497, doi. 10.1080/10428194.2024.2425048

By:

Jabban, Yazan;
Yacout, Mahmoud;
Baranwal, Anmol;
He, Rong;
Viswanatha, David;
Greipp, Patricia;
Jevremovic, Dragan;
Bessonen, Kurt;
Foran, James;
Palmer, Jeanne;
Saliba, Antoine N.;
Hefazi-Torghabeh, Mehrdad;
Begna, Kebede;
Hogan, William J.;
Mangaonkar, Abhishek;
Patnaik, Mrinal;
Shah, Mithun;
Alkhateeb, Hassan;
Al-Kali, Aref

Publication type:

Article

Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis.

Published in:

Leukemia & Lymphoma, 2022, v. 63, n. 1, p. 199, doi. 10.1080/10428194.2021.1971217

By:

Komrokji, Rami;
Melody, Megan;
al Ali, Najla;
Chan, Onyee;
Klimek, Virginia;
Ball, Brian J.;
Sekeres, Mikkael A.;
Lucas, George;
Maciejewski, Jaroslaw P.;
Sallman, David A.;
Padron, Eric;
Kuykendall, Andrew;
Lasho, Terra;
Al-Kali, Aref;
Naqvi, Kiran;
Steensma, David P.;
Garcia-Manero, Guillermo;
Patnaik, Mrinal M.

Publication type:

Article

Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experience.

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 10, p. 2483, doi. 10.1080/10428194.2019.1581930

By:

Baidoun, Firas;
Chen, Dong;
Patnaik, Mrinal;
Gangat, Naseema;
Begna, Kebede;
Elliott, Michelle;
Hogan, William;
Litzow, Mark;
Al-Kali, Aref

Publication type:

Article

Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients.

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 4, p. 990, doi. 10.1080/10428194.2018.1509318

By:

Miller, Kevin C.;
Al-Kali, Aref;
Shah, Mithun V.;
Hogan, William J.;
Elliott, Michelle A.;
Begna, Kebede H.;
Gangat, Naseema;
Patnaik, Mrinal M.;
Viswanatha, David S.;
He, Rong;
Greipp, Patricia T.;
Sproat, Lisa Z.;
Foran, James M.;
Litzow, Mark R.;
Alkhateeb, Hassan B.

Publication type:

Article

A case of ibrutinib-associated aspergillosis presenting with central nervous system, myocardial, pulmonary, intramuscular, and subcutaneous abscesses.

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 2, p. 559, doi. 10.1080/10428194.2018.1494271

By:

McCarter, Stuart J.;
Vijayvargiya, Prakhar;
Wilson, John W.;
Sidana, Surbhi;
Parikh, Sameer A.;
Nowakowski, Grzegorz S.;
Al-Kali, Aref;
Nault, Ashley M.;
Lehman, Julia S.;
Lane, Colleen E.

Publication type:

Article

Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia.

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 1, p. 246, doi. 10.1080/10428194.2018.1468893

By:

Stahl, Maximilian;
DeVeaux, Michelle;
Montesinos, Pau;
Itzykson, Raphaël;
Ritchie, Ellen K.;
Sekeres, Mikkael A.;
Barnard, John;
Podoltsev, Nikolai A.;
Brunner, Andrew;
Komrokji, Rami S.;
Bhatt, Vijaya R.;
Al-Kali, Aref;
Cluzeau, Thomas;
Santini, Valeria;
Roboz, Gail J.;
Fenaux, Pierre;
Litzow, Mark;
Fathi, Amir T.;
Perreault, Sarah;
Kim, Tae Kon

Publication type:

Article

Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience.

Published in:

Leukemia & Lymphoma, 2018, v. 59, n. 11, p. 2737, doi. 10.1080/10428194.2018.1436705

By:

Al-Kali, Aref;
Abou Hussein, Ahmed Kamel;
Patnaik, Mrinal;
Zblewski, Darci;
Gangat, Naseema;
Hashmi, Shahrukh;
Elliott, Michelle;
Hogan, William;
Litzow, Mark

Publication type:

Article

Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia.

Published in:

2018

By:

Larsen, Carolyn M.;
Villarraga, Hector R.;
Begna, Kebede H.;
Litzow, Mark R.;
Al-Kali, Aref;
Herrmann, Joerg

Publication type:

Letter to the Editor

Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy.

Published in:

Leukemia & Lymphoma, 2017, v. 58, n. 11, p. 2588, doi. 10.1080/10428194.2017.1312384

By:

Barreto, Jason N.;
McCullough, Kristen B.;
Peskey, Candy S.;
Dierkhising, Ross A.;
Mara, Kristin C.;
Elliott, Michelle A.;
Gastineau, Dennis A.;
Al-Kali, Aref;
Gangat, Naseema;
Letendre, Louis;
Hogan, William J.;
Litzow, Mark R.;
Patnaik, Mrinal M.

Publication type:

Article

Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes.

Published in:

Leukemia & Lymphoma, 2017, v. 58, n. 4, p. 872, doi. 10.1080/10428194.2016.1217529

By:

Sharma, Prashant;
Shinde, Shivani S.;
Damlaj, Moussab;
Hefazi Rorghabeh, Mehrdad;
Hashmi, Shahrukh K.;
Litzow, Mark R.;
Hogan, William J.;
Gangat, Naseema;
Elliott, Michelle A.;
Al-Kali, Aref;
Tefferi, Ayalew;
Patnaik, Mrinal M.

Publication type:

Article

Hypomethylating agents are effective in shrinking splenomegaly in patients with chronic myelomonocytic leukemia.

Published in:

2016

By:

Subari, Salih;
Patnaik, Mrinal;
Alfakara, Dima;
Zblewski, Darci;
Hook, Chris;
Hashmi, Shahrukh;
Hogan, William;
Litzow, Mark;
Al-Kali, Aref

Publication type:

Letter to the Editor

Toxoplasmosis in patients with hematologic malignancies.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 2, p. 536, doi. 10.3109/10428194.2014.926348

By:

Chintakuntlawar, Ashish;
Kidd, Michael;
Al-Kali, Aref;
Wilson, Walter;
Thompson, Carrie A.

Publication type:

Article

Comparison of complication rates of Hickman<sup>®</sup> catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy.

Published in:

Leukemia & Lymphoma, 2013, v. 54, n. 6, p. 1263, doi. 10.3109/10428194.2012.742520

By:

Lim, Ming Y.;
Al-Kali, Aref;
Ashrani, Aneel A.;
Begna, Kebede H.;
Elliott, Michelle A.;
Hogan, William J.;
Hook, C. Christopher;
Kaufmann, Scott H.;
Letendre, Louis;
Litzow, Mark R.;
Patnaik, Mrinal S.;
Pardanani, Animesh;
Tefferi, Ayalew;
Wolanskyj, Alexandra P.;
Grill, Diane E.;
Pruthi, Rajiv K.

Publication type:

Article

TP53 Mutations in Myeloproliferative Neoplasms: Context‐Dependent Evaluation of Prognostic Relevance.

Published in:

American Journal of Hematology, 2025, v. 100, n. 4, p. 552, doi. 10.1002/ajh.27609

By:

Tefferi, Ayalew;
Abdelmagid, Maymona;
Loscocco, Giuseppe G.;
Fathima, Saubia;
Begna, Kebede H.;
Al‐Kali, Aref;
Foran, James;
Palmer, Jeanne;
Badar, Talha;
Patnaik, Mrinal M.;
Reichard, Kaaren K.;
He, Rong;
Zepeda Mendoza, Cinthya J.;
Shah, Mithun;
Orazi, Attilio;
Arber, Daniel A.;
Pardanani, Animesh;
Vannucchi, Alessandro M.;
Hiwase, Devendra;
Gangat, Naseema

Publication type:

Article

Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.

Published in:

American Journal of Hematology, 2025, v. 100, n. 2, p. 260, doi. 10.1002/ajh.27564

By:

Gangat, Naseema;
Elbeih, Azeem;
Ghosoun, Nour;
McCullough, Kristen;
Aperna, Fnu;
Johnson, Isla M.;
Abdelmagid, Maymona;
Al‐Kali, Aref;
Alkhateeb, Hassan B.;
Begna, Kebede H.;
Elliott, Michelle;
Mangaonkar, Abhishek;
Matin, Aasiya;
Saliba, Antoine N.;
Hefazi Torghabeh, Mehrdad;
Litzow, Mark R.;
Hogan, William;
Shah, Mithun;
Patnaik, Mrinal M.;
Pardanani, Animesh

Publication type:

Article

PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis.

Published in:

American Journal of Hematology, 2024, v. 99, n. 12, p. 2321, doi. 10.1002/ajh.27492

By:

Tefferi, Ayalew;
Fathima, Saubia;
Alsugair, Ali Khalid A.;
Aperna, Fnu;
Natu, Anuya;
Abdelmagid, Maymona G.;
Csizmar, Clifford M.;
Gurney, Mark;
Lasho, Terra L.;
Finke, Christy M.;
Mangaonkar, Abhishek A.;
Al‐Kali, Aref;
Pardanani, Animesh;
Reichard, Kaaren K.;
He, Rong;
Gangat, Naseema;
Patnaik, Mrinal M.

Publication type:

Article

Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.

Published in:

American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180

By:

Karrar, Omer;
Abdelmagid, Maymona;
Rana, Masooma;
Iftikhar, Moazah;
McCullough, Kristen;
Al‐Kali, Aref;
Alkhateeb, Hassan B.;
Begna, Kebede H.;
Elliott, Michelle A.;
Mangaonkar, Abhishek;
Saliba, Antoine;
Hefazi Torghabeh, Mehrdad;
Litzow, Mark R.;
Hogan, William;
Shah, Mithun;
Patnaik, Mrinal M.;
Pardanani, Animesh;
Badar, Talha;
Murthy, Hemant;
Foran, James

Publication type:

Article

Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.

Published in:

American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138

By:

Gangat, Naseema;
Karrar, Omer;
Iftikhar, Moazah;
McCullough, Kristen;
Johnson, Isla M.;
Abdelmagid, Maymona;
Abdallah, Mostafa;
Al‐Kali, Aref;
Alkhateeb, Hassan B.;
Begna, Kebede H.;
Mangaonkar, Abhishek;
Saliba, Antoine N.;
Hefazi Torghabeh, Mehrdad;
Litzow, Mark R.;
Hogan, William;
Shah, Mithun;
Patnaik, Mrinal M.;
Pardanani, Animesh;
Badar, Talha;
Murthy, Hemant

Publication type:

Article

Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases.

Published in:

American Journal of Hematology, 2024, v. 99, n. 1, p. 21, doi. 10.1002/ajh.27113

By:

Tefferi, Ayalew;
Abdelmagid, Maymona;
Al‐Kali, Aref;
Patnaik, Mrinal;
Hogan, William J.;
Begna, Kebede;
Gangat, Naseema;
Orazi, Attilio;
Chen, Dong;
Reichard, Kaaren K.;
Pardanani, Animesh

Publication type:

Article

Mast cell cytomorphology and treatment outcome in mast cell leukemia.

Published in:

American Journal of Hematology, 2024, v. 99, n. 1, p. E5, doi. 10.1002/ajh.27105

By:

Tefferi, Ayalew;
Pardanani, Animesh;
Al‐Kali, Aref;
Alkhateeb, Hassan;
McCullough, Kristen;
Patnaik, Mrinal;
Hogan, William J.;
Begna, Kebede;
Elliott, Michelle A.;
Khera, Nandita;
Palmer, Jeanne M.;
Gangat, Naseema;
Kelemen, Katalin;
Orazi, Attilio;
Chen, Dong;
Reichard, Kaaren K.

Publication type:

Article

Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.

Published in:

American Journal of Hematology, 2024, v. 99, n. 1, p. E1, doi. 10.1002/ajh.27089

By:

Pardanani, Animesh;
Tefferi, Ayalew;
Al‐Kali, Aref;
Patnaik, Mrinal;
Hogan, William J.;
Begna, Kebede;
Elliott, Michelle A.;
Khera, Nandita;
Palmer, Jeanne M.;
Gangat, Naseema;
Orazi, Attilio;
Kelemen, Katalin;
Reichard, Kaaren K.;
Chen, Dong

Publication type:

Article

Sodium‐glucose co‐transporter‐2 inhibitor use and JAK2 unmutated erythrocytosis in 100 consecutive cases.

Published in:

American Journal of Hematology, 2023, v. 98, n. 7, p. E165, doi. 10.1002/ajh.26933

By:

Gangat, Naseema;
Abdallah, Mostafa;
Szuber, Natasha;
Saliba, Antoine;
Alkhateeb, Hassan;
Al‐Kali, Aref;
Begna, Kebede H.;
Pardanani, Animesh;
Tefferi, Ayalew

Publication type:

Article

Spectrum of renal pathological findings in patients with chronic myelomonocytic leukemia and kidney injury.

Published in:

American Journal of Hematology, 2023, v. 98, n. 6, p. E148, doi. 10.1002/ajh.26902

By:

Gipe, Nate;
Leung, Nelson;
Lasho, Terra;
Mangaonkar, Abhishek;
Alkhateeb, Hassan;
Al‐Kali, Aref;
Gangat, Naseema;
Hogan, William;
McCullough, Kristen;
Tefferi, Ayalew;
Alexander, Mariam Priya;
Patnaik, Mrinal M.

Publication type:

Article

TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases.

Published in:

American Journal of Hematology, 2023, v. 98, n. 4, p. E76, doi. 10.1002/ajh.26845

By:

Fleti, Farah;
Chan, Onyee;
Singh, Amritpal;
Abdelmagid, Maymona G.;
Al‐Kali, Aref;
Elliott, Michelle A.;
Begna, Kebede H.;
Foran, James M.;
Badar, Talha;
Khera, Nandita;
Al Ali, Najla H.;
Padron, Eric;
Sallman, David A.;
Shah, Mithun;
Hiwase, Devendra;
Pardanani, Animesh;
Arber, Daniel A.;
Orazi, Attilio;
Reichard, Kaaren K.;
He, Rong

Publication type:

Article

A phase II study of combination d aunorubicin, cytarabine (A ra‐c), and nilotinib (TA signa) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression.

Published in:

American Journal of Hematology, 2023, v. 98, n. 3, p. 472, doi. 10.1002/ajh.26831

By:

Al‐Kali, Aref;
Tibes, Raoul;
Atherton, Pamela;
Palmer, Jeanne;
Alkhateeb, Hassan B.;
Patnaik, Mrinal;
Begna, Kebede;
Gangat, Naseema;
Hashmi, Shahrukh;
He, Rong;
Litzow, Mark

Publication type:

Article

Predictors of anemia response to momelotinib therapy in myelofibrosis and impact on survival.

Published in:

American Journal of Hematology, 2023, v. 98, n. 2, p. 282, doi. 10.1002/ajh.26778

By:

Gangat, Naseema;
Begna, Kebede H.;
Al‐Kali, Aref;
Hogan, William;
Litzow, Mark;
Pardanani, Animesh;
Tefferi, Ayalew

Publication type:

Article

Limited activity of luspatercept in myelofibrosis and myeloid neoplasms other than myelodysplastic syndromes with ring sideroblasts.

Published in:

American Journal of Hematology, 2022, v. 97, n. 12, p. E474, doi. 10.1002/ajh.26749

By:

Gangat, Naseema;
Chetram, Deandra;
McCullough, Kristen;
Al‐Kali, Aref;
Begna, Kebede;
Hogan, William;
Litzow, Mark;
Foran, James;
Badar, Talha;
Palmer, Jeanne;
Patnaik, Mrinal;
Pardanani, Animesh;
Tefferi, Ayalew

Publication type:

Article

Momelotinib for myelofibrosis: 12‐year survival data and retrospective comparison to ruxolitinib.

Published in:

American Journal of Hematology, 2022, v. 97, n. 12, p. E433, doi. 10.1002/ajh.26714

By:

Tefferi, Ayalew;
Pardanani, Animesh;
Begna, Kebede H.;
Al‐Kali, Aref;
Hogan, William J.;
Litzow, Mark R.;
Hanson, Curtis A.;
Ketterling, Rhett P.;
Gangat, Naseema

Publication type:

Article